Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG/SIOP prospective study.

[1]  T. Merchant,et al.  CSF cytology has limited value in the evaluation of patients with ependymoma who have MRI evidence of metastasis , 2006, Pediatric blood & cancer.

[2]  Douglas C. Miller,et al.  Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  S. Kellie,et al.  Late magnetic resonance imaging features of leukoencephalopathy in children with central nervous system tumours following high-dose methotrexate and neuraxis radiation therapy. , 2005, European journal of cancer.

[4]  T. Pietsch,et al.  Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. , 2005, The New England journal of medicine.

[5]  S. Williams,et al.  Proceedings of the Engineering and Physical Sciences Research Council Workshop—the development of functional imaging in the diagnosis, management and understanding of childhood brain tumours , 2005, Pediatric blood & cancer.

[6]  S. Coons,et al.  Is gross-total resection sufficient treatment for posterior fossa ependymomas? , 2002, Journal of neurosurgery.

[7]  S. Weitman,et al.  The folate receptor in central nervous system malignancies of childhood , 2005, Journal of Neuro-Oncology.

[8]  R. Mulhern,et al.  Preliminary results from a phase II trial of conformal radiation therapy and evaluation of radiation-related CNS effects for pediatric patients with localized ependymoma. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  F. Kirkham,et al.  Toxicity and late effects , 2004 .

[10]  Amar Gajjar,et al.  Late neurocognitive sequelae in survivors of brain tumours in childhood. , 2004, The Lancet. Oncology.

[11]  A. Korshunov,et al.  The histologic grade is a main prognostic factor for patients with intracranial ependymomas treated in the microneurosurgical era , 2004, Cancer.

[12]  Eric Bouffet,et al.  Change in neurocognitive functioning after treatment with cranial radiation in childhood. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  C. Sainte-Rose,et al.  Ependymoma in childhood: prognostic factors, extent of surgery, and adjuvant therapy. , 2002, Journal of neurosurgery.

[14]  D Machin,et al.  Competing risks analysis of patients with osteosarcoma: a comparison of four different approaches , 2001, Statistics in medicine.

[15]  D. Frappaz,et al.  Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  D. Machin,et al.  Received dose and dose-intensity of chemotherapy and outcome in nonmetastatic extremity osteosarcoma. European Osteosarcoma Intergroup. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  D. Riva,et al.  The neurodevelopmental price of survival in children with malignant brain tumours , 2000, Child's Nervous System.

[18]  D. Figarella-Branger,et al.  Prognostic factors in intracranial ependymomas in children. , 2000, Journal of neurosurgery.

[19]  Webster K. Cavenee,et al.  Pathology and genetics of tumours of the nervous system. , 2000 .

[20]  C. Meisner,et al.  Combined postoperative irradiation and chemotherapy for anaplastic ependymomas in childhood: results of the German prospective trials HIT 88/89 and HIT 91. , 2000, International journal of radiation oncology, biology, physics.

[21]  B. Moore,et al.  Neurocognitive development of children after a cerebellar tumor in infancy: A longitudinal study. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  K. Lamborn,et al.  A multi-institutional retrospective study of intracranial ependymoma in children: identification of risk factors. , 1999, Journal of pediatric hematology/oncology.

[23]  J. Krischer,et al.  Second malignancies in young children with primary brain tumors following treatment with prolonged postoperative chemotherapy and delayed irradiation: A pediatric oncology group study , 1998, Annals of neurology.

[24]  G. Perilongo,et al.  Intracranial ependymomas in children: a critical review of prognostic factors and a plea for cooperation. , 1998, Medical and pediatric oncology.

[25]  L. Rorke,et al.  Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group. , 1998, Journal of neurosurgery.

[26]  J. Krischer,et al.  Prognostic Factors in Infants and Very Young Children with Intracranial Ependymomas , 1998, Pediatric Neurosurgery.

[27]  I. Toogood,et al.  Postoperative Chemotherapy in Children Less Than 4 Years of Age with Malignant Brain Tumors: Promising Initial Response to a VETOPEC‐Based Regimen A Study of the Australian and New Zealand Children's Cancer Study Group (ANZCCSG) , 1998, Journal of pediatric hematology/oncology.

[28]  M. Carli,et al.  Analyses of prognostic factors in a retrospective review of 92 children with ependymoma: Italian Pediatric Neuro-oncology Group. , 1997, Medical and pediatric oncology.

[29]  H. Gattamaneni,et al.  An intensive multiagent chemotherapy regimen for brain tumours occurring in very young children. , 1996, Archives of disease in childhood.

[30]  David Machin,et al.  Survival Analysis: A Practical Approach , 1995 .

[31]  P. Gerszten,et al.  Intracranial ependymomas of childhood: long-term outcome and prognostic factors. , 1995, Neurosurgery.

[32]  A. Gnekow.  Recommendations of the Brain Tumor Subcommittee for the reporting of trials. SIOP Brain Tumor Subcommittee. International Society of Pediatric Oncology. , 1995, Medical and pediatric oncology.

[33]  L. Rorke,et al.  Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Childrens Cancer Group. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  J. Habrand,et al.  Treatment of intracranial ependymomas of children: review of a 15-year experience. , 1994, International journal of radiation oncology, biology, physics.

[35]  M E Cohen,et al.  Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. , 1993, The New England journal of medicine.

[36]  W. Curran,et al.  Intracranial ependymomas in children. , 1990, International journal of radiation oncology, biology, physics.

[37]  W. Curran,et al.  Recurrent intracranial ependymomas in children survival, patterns of failure, and prognostic factors , 1990, Cancer.

[38]  L. Rorke,et al.  Prognostic factors in childhood ependymomas. , 1990, Pediatric neurosurgery.

[39]  E. Olsson,et al.  Long-term sequelae after pediatric brain tumors: their effect on disability and quality of life. , 1990, Medical and pediatric oncology.

[40]  G. Rosen,et al.  Preradiation high-dose intravenous methotrexate with leucovorin rescue for untreated primary childhood brain tumors. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  B. Scheithauer,et al.  Postoperative radiotherapy of intracranial ependymoma in pediatric and adult patients. , 1987, International journal of radiation oncology, biology, physics.

[42]  P. Rubin,et al.  Improved survival in cases of intracranial ependymoma after radiation therapy. Late report and recommendations. , 1983, Journal of neurosurgery.

[43]  W. Bleyer.  Neurologic sequelae of methotrexate and ionizing radiation: a new classification. , 1981, Cancer treatment reports.

[44]  G. Rosen,et al.  Leukoencephalopathy following high-dose iv methotrexate chemotherapy with leucovorin rescue. , 1980, Cancer treatment reports.

[45]  H. Abelson.  Methotrexate and central nervous system toxicity. , 1978, Cancer treatment reports.